Menu

Nick

17 posts

Posts (17)

Nick IOVA 1 year ago #1

$IOVA How fun watching the shorts squirm ?

Nick IOVA 1 year ago #2

$IOVA Oh Ed! Changed your pic I see. How much are you going to lose on this one??

Nick IOVA 1 year ago #3

$IOVA They are burning the $2 puts.

Nick IOVA 1 year ago #4

$IOVA Where is Ken??? Where are you buddy??

Nick IOVA 1 year ago #7

$IOVA Ken, what’s your deal here? What is your ultimate goal? You’ve posted over and over again about why you think this is trash, a scam etc. but you keep coming back every day to say the same. Why?

Nick ARQT 2 years ago #8

$ARQT Over the past 90 days, the Zacks Consensus Estimate for ARQT's full-year earnings has moved 35.7% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the latest available data, ARQT has gained about 202.5% so far this year. At the same time, Medical stocks have gained an average of 5.6%. This means that Arcutis Biotherapeutics, Inc. is outperforming the sector as a whole this year.

Nick ARQT 2 years ago #9

$ARQT ARQT Sales Forecast
Next quarter’s sales forecast for ARQT is $36.36M with a range of $35.70M to $38.00M. The previous quarter’s sales results were $30.86M. ARQT beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 46.76% of the time in the same period. In the last calendar year ARQT has Outperformed its overall industry.

Nick ARQT 2 years ago #10

$ARQT ARQT Earnings Forecast
Next quarter’s earnings estimate for ARQT is -$0.41 with a range of -$0.44 to -$0.38. The previous quarter’s EPS was -$0.42. ARQT beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year ARQT has Outperformed its overall industry.